Table 3c.
Wait time | 31–59 days vs. 0–30 days 1 | 2–6 months vs. 0–30 days 2 | Over 6 months vs. 0–30 days 3 | |||
---|---|---|---|---|---|---|
(N=87380, N-adjusted= 86956) | (N=104987, N-adjusted= 104439) | (N=105289, N-adjusted= 104550) | ||||
Follow-up time after entry | cHR(95%CI) | aHR(95%CI) 4 | cHR(95%CI) | aHR(95%CI) 4 | cHR(95%CI) | aHR(95%CI) 4 |
Within 1 year | 0.98(0.95, 1.01) | 1.00(0.97, 1.03) *** | ||||
After 1 year | 1.07(1.04, 1.09) | 1.04(1.02, 1.07) *** | ||||
Within 2 years | 0.87(0.85, 0.89) | 0.90(0.88, 0.92) *** | ||||
After 2 years | 1.09(1.06, 1.12) | 1.07(1.04, 1.11) *** | ||||
Within 2 years | 0.74(0.73, 0.76) | 0.79(0.77, 0.80) *** | ||||
After 2 years | 1.12(1.08, 1.15) | 1.10(1.06, 1.13) *** |
*** P<0.0001; cHR: crude Hazard Ratio, aHR: adjusted Hazard Ratio; 1. Model N=86956 (missing data=424/87380, 0.5%); 2Model N=104439 (missing data=548/104987, 0.5%); 3Model N=104550 (missing data= 739/105289, 0.7%); 4. All models adjusted for covariates associated with wait time: age, sex, country of birth, indigenous status, living arrangements, remoteness, usual accommodation, activity limitations (communication, domestic assistance, health care tasks, meals, movement activities, self-care, social and community participation, transport, moving around places at or away from home), approval for (permanent, respite, transition care), health conditions (hypertension, falls, arthritis, diseases of the skin and subcutaneous tissue, cancer, delirium, dementia, depression, diabetes, fracture).